McKesson Corporation (MCK) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, inde...
McKesson Corporation (MCK) currently trades at a P/E ratio of 25.61 (historical range: 20.74–33.71, median: 27.12), placing it at the 39th percentile — below its historical average, P/S ratio of 0.28 (range: 0.20–0.31, 85th percentile — expensive relative to its history), EV/EBITDA of 18.31 (range: 14.90–97.41, 20th percentile).
McKesson Corporation appears fairly valued relative to its historical range, with valuation metrics near their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 25.61 | 20.74 | 27.12 | 33.71 | 39th | below its historical average |
| P/S Ratio | 0.28 | 0.20 | 0.25 | 0.31 | 85th | expensive relative to its history |
| EV/EBITDA | 18.31 | 14.90 | 29.90 | 97.41 | 20th | below its historical average |
| FCF Yield | 0.05 | 0.01 | 0.05 | 0.07 | 43th | near its historical average |